{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:43:06Z","timestamp":1790714586472,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T00:00:00Z","timestamp":1413244800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0110143","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T18:09:29Z","timestamp":1413310169000},"page":"e110143","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":52,"title":["The Impact of Vaccination and Antiviral Therapy on Hepatitis B and Hepatitis D Epidemiology"],"prefix":"10.1371","volume":"9","author":[{"given":"Ashish","family":"Goyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(05)00384-7","article-title":"Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention","volume":"34","author":"D Lavanchy","year":"2005","journal-title":"J Clin Virol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"D Lavanchy","year":"2004","journal-title":"J Viral Hepat"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.vaccine.2005.03.017","article-title":"Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants","volume":"23","author":"D Fitzsimons","year":"2005","journal-title":"Vaccine"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1542\/peds.2006-0724","article-title":"Near elimination of hepatitis B virus infections among Hawaii elementary school children after universal infant hepatitis B vaccination","volume":"118","author":"JF Perz","year":"2006","journal-title":"Pediatrics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"DM Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3748\/wjg.v16.i5.554","article-title":"Hepatitis D: Scenario in the Asia-Pacific region","volume":"16","author":"Z Abbas","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bonino F, Rizzetto M (1989) Hepatitis Delta Virus in Acute and Chronic Liver Disease. In: Gitnick G, editor. Modern Concepts of Acute and Chronic Hepatitis: Springer US. pp. 113\u2013126.","DOI":"10.1007\/978-1-4615-9519-9_8"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2893.2010.01324.x","article-title":"Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study","volume":"18","author":"M Buti","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref9","unstructured":"Purcell RH, Gerin JL (1996) Hepatitis Delta virus. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology, 3rd ed. Philadelphia: Lippincott-Raven. pp. 2819\u20132829."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrgastro.2009.205","article-title":"Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead","volume":"7","author":"H Wedemeyer","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","first-page":"211","article-title":"Epidemiology of hepatitis D. Semin Liver Dis","volume":"32","author":"M Rizzetto","year":"2012"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2217\/fvl.12.61","article-title":"Epidemiology and diagnosis of hepatitis D virus","volume":"7","author":"GAF Niro","year":"2012","journal-title":"Future Virology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4300","DOI":"10.3748\/wjg.14.4300","article-title":"Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis","volume":"14","author":"AI Gomaa","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S0168-8278(03)00141-7","article-title":"Epidemiology of hepatitis B in Europe and worldwide","volume":"39","author":"MJ Alter","year":"2003","journal-title":"J Hepatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0016-5085(03)00895-3","article-title":"Hepatitis B virus genotypes in the United States: results of a nationwide study","volume":"125","author":"CJ Chu","year":"2003","journal-title":"Gastroenterology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e5247","DOI":"10.1371\/journal.pone.0005247","article-title":"How hepatitis D virus can hinder the control of hepatitis B virus","volume":"4","author":"M Xiridou","year":"2009","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1128\/CMR.6.3.211","article-title":"Delta hepatitis: molecular biology and clinical and epidemiological features","volume":"6","author":"LB Polish","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.bi.64.070195.001355","article-title":"The molecular biology of hepatitis delta virus","volume":"64","author":"MM Lai","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ije\/29.4.744","article-title":"A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China","volume":"29","author":"S Zhao","year":"2000","journal-title":"Int J Epidemiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/87953","article-title":"Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control","volume":"7","author":"GF Medley","year":"2001","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jtbi.2010.05.038","article-title":"Dynamical behavior of a hepatitis B virus transmission model with vaccination","volume":"265","author":"J Pang","year":"2010","journal-title":"J Theor Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jtbi.2009.09.035","article-title":"Modeling the transmission dynamics and control of hepatitis B virus in China","volume":"262","author":"L Zou","year":"2010","journal-title":"J Theor Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0035-9203(96)90539-8","article-title":"Vaccination against hepatitis B virus in highly endemic areas: waning vaccine-induced immunity and the need for booster doses","volume":"90","author":"WJ Edmunds","year":"1996","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3949\/ccjm.75a.07019","article-title":"Hepatitis B virus infection: understanding its epidemiology, course, and diagnosis","volume":"75","author":"HM Elgouhari","year":"2008","journal-title":"Cleve Clin J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China\u2013declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"X Liang","year":"2009","journal-title":"Vaccine"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1111\/j.1572-0241.2002.07057.x","article-title":"Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients","volume":"97","author":"G Fattovich","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"ref27","first-page":"S50","article-title":"Natural history of hepatitis B. J Hepatol","volume":"39","author":"G Fattovich","year":"2003"},{"key":"ref28","first-page":"47","article-title":"Natural history and prognosis of hepatitis B. Semin Liver Dis","volume":"23","author":"G Fattovich","year":"2003"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00004836-200205000-00018","article-title":"Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation","volume":"34","author":"AY Hui","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1542-3565(04)00386-6","article-title":"Treatment of chronic hepatitis B: who to treat, what to use, and for how long?","volume":"2","author":"SK Fung","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref31","unstructured":"World Health Organization (2001) Hepatitis D."},{"key":"ref32","unstructured":"MOHC (2013) Ministry of Health of the People's Republic of China."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"e47808","DOI":"10.1371\/journal.pone.0047808","article-title":"Effectiveness of HBV vaccination in infants and prediction of HBV prevalence trend under new vaccination plan: findings of a large-scale investigation","volume":"7","author":"SG Yang","year":"2012","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e8467","DOI":"10.1371\/journal.pone.0008467","article-title":"General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007","volume":"4","author":"J Lu","year":"2009","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.24758","article-title":"Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation","volume":"55","author":"M Lutgehetmann","year":"2012","journal-title":"Hepatology"},{"key":"ref36","first-page":"2","article-title":"Treatment of hepatitis D. J Viral Hepat","volume":"12","author":"GA Niro","year":"2005"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1172\/JCI17704","article-title":"In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus","volume":"112","author":"BB Bordier","year":"2003","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1128\/JVI.76.20.10465-10472.2002","article-title":"A prenylation inhibitor prevents production of infectious hepatitis delta virus particles","volume":"76","author":"BB Bordier","year":"2002","journal-title":"J Virol"},{"key":"ref39","first-page":"539","article-title":"Testing antivirals against hepatitis delta virus: farnesyl transferase inhibitors","volume":"96","author":"BB Bordier","year":"2004","journal-title":"Methods Mol Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jmv.23212","article-title":"Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China","volume":"84","author":"L Shen","year":"2012","journal-title":"J Med Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e56444","DOI":"10.1371\/journal.pone.0056444","article-title":"Prevalence of hepatitis B in insular regions of southeast China: a community-based study","volume":"8","author":"P Chen","year":"2013","journal-title":"PLoS One"},{"key":"ref42","unstructured":"The World Bank (2013) Pregnant women receiving prenatal care. The World Bank."},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/JCM.40.8.3047-3049.2002","article-title":"Hepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes","volume":"40","author":"JH Kao","year":"2002","journal-title":"J Clin Microbiol"},{"key":"ref44","unstructured":"BUREAU OF DEMOCRACY HR, AND LABOR (2010) 2009 Human Rights Report: China (includes Tibet, Hong Kong, and Macau)."},{"key":"ref45","unstructured":"UNICEF (2013) China-Statistics. unicef."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0110143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:52:57Z","timestamp":1588978377000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0110143"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,14]]},"references-count":45,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0110143","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,14]]}}}